Clinical trial
Hydroxyzine and Risk of Prolongation of QT Interval
NCT02814981 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxyzine and Risk of Prolongation of QT Interval
- Lead sponsor
- University Hospital, Caen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- October 31, 2017
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hydroxyzine, long qt syndrome